Insiders Updates Wells Fargo upgrades Regulus Therapeutics Inc (RGLS) rating to an Overweight In a filing, Regulus Therapeutics Inc revealed its President & Head of R & D Klassen Preston acquired Company’s shares
News What Is Raising Regulus Therapeutics (RGLS) Stock This Morning? Regulus Therapeutics Inc. (RGLS) shares gained 15.69% to $1.92 in Monday’s early session after reporting positive clinical trial results. A